LOS ANGELES – Financier Carl Icahn (search) on Friday offered to buy the shares of generic drugmaker Mylan Laboratories (MYL) that he does not already own for $4.9 billion, or $20 a share, according ...

WASHINGTON (CBS.MW) -- Mylan Laboratories , responding to the latest in a series of letters from investor Carl Icahn, reasserted its position that acquiring King Pharmaceuticals is in the long-term ...

PITTSBURGH – Generic drug maker Mylan Laboratories Inc. (MYL) is buying branded drug maker King Pharmaceuticals Inc. (KG) for about $4 billion in stock, company officials said Monday. Mylan has ...

Mylan Laboratories said on Monday it agreed to acquire troubled drugmaker King Pharmaceuticals Inc. for about $4 billion, adding patent-protected brand drugs to Mylan’s generic-drug offerings. Under ...

Mylan Labs Mylan Announces Pricing of Tender Offers for its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 PITTSBURGH, Sept. 17 -- Mylan Laboratories Inc. (NYSE:MYL) ("Mylan") announced ...

The early reaction to the pairing of generic drug maker Mylan Laboratories and Pfizer’s generics unit, Upjohn — officially announced Monday — is that it’s great for Mylan but maybe not so amazing for ...

NEW YORK, Feb 1 (Reuters) - Mylan Laboratories Inc. said on Thursday that quarterly profit more than doubled, and reported better-than-expected sales, helped by its generic version of the Ditropan XL ...

Pittsburgh-based Mylan Labs will purchase 71.5% of the shares of Hyderabad, India-based Matrix Labs for about $736 million. Matrix will remain a publicly traded company in India and will continue to ...

NEW YORK, Jan 31 (Reuters) - Mylan Laboratories Inc. said on Wednesday it was reorganizing its executive ranks after acquiring a controlling interest in India's Matrix Laboratories Ltd. , and that ...

SAN FRANCISCO (MarketWatch) -- Mylan Laboratories Inc. and Forest Laboratories Inc.'s Forest Laboratories Holdings Ltd. said late Wednesday they have entered into an agreement for the ...